Use and monitoring of "statin" lipid-lowering drugs compared with guidelines

Archives of Internal Medicine

Volumn 161, Issue 1, 2001, Pages 53-58

  Abookire, Susan A ^a,b   Karson, Andrew S ^a   Fiskio, Julie ^b   Bates, David W ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Partners Information Systems   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STATIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CORONARY ARTERY DISEASE; DRUG MONITORING; EDUCATION PROGRAM; FEMALE; HUMAN; HYPERLIPIDEMIA; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TREATMENT INDICATION;

EID: 0035825294     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.1.53     Document Type: Article

References (32)

1. Serum cholesterol, lipoproteins, and the risk of coronary heart disease: The Framingham study
2. Multiple Risk Factor Intervention Trial: Risk factor changes and mortality results
3. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II)
4. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
5. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
6. Prevention of cardiovascular events with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
7. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
8. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
9. Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease
10. Adherence to National Cholesterol Education Program treatment goals in postmenopausal women with heart disease: The Heart and Estrogen/ Progestin Replacement Study (HERS)
11. Variations in cholesterol management practices of US physicians
12. A comparison of primary vs secondary cardiovascular disease prevention in an academic family practice
13. Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease
14. Toward cost-effective, quality care: The Brigham Integrated Computing System
15. The accuracy of medication data in an outpatient electronic medical record
16. Comparison of effects on sleep of lovastatin and pravastatin in hypercholesterolemia
17. Extended clinical safety profile of lovastatin
18. Choice of lipid-lowering drugs
19. National patterns in the treatment of smokers by physicians
20. Communication between older adults and their physicians about urinary incontinence
21. Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease
22. Cholesterol screening in asymptomatic adults, revisited: Part 2
23. Canadian Consensus Conference on Cholesterol: Final report: The Canadian Consensus Conference on the Prevention of Heart and Vascular Disease by Altering Serum Cholesterol and Lipoprotein Risk Factors
24. Evaluation of clinical practice guidelines
25. Do practice guidelines guide practice? The effects of a consensus statement on the practice of physicians
26. Changing physician performance: A systematic review of the effect of continuing medical education strategies
27. Changing physician behavior to improve disease prevention
28. Changing physician behavior to increase guideline implementation
29. Effect of computerized order entry and a team intervention on prevention of serious medication errors
30. A computerized alert system to prevent injury from adverse drug events: Development and evaluation in a community teaching hospital
31. A randomized trial of "corollary orders" to prevent errors of omission